diamonds

Resources

Clinical Insight

Product Focus: Gemtesa® (Vibegron)

Product Focus: Gemtesa® (Vibegron)

Printer Friendly PDF Description: Vibegron is a selective beta-3 adrenergic agonist. Like mirabegron, vibegron relaxes detrusor smooth muscle and increases bladder capacity, reducing incontinence. Indication & Dosage: For the treatment of overactive bladder (OAB)...

Restless Legs Syndrome – Treatment Recommendations

Restless Legs Syndrome – Treatment Recommendations

Printer Friendly PDF What is restless legs syndrome (RLS)? RLS is a condition characterized by a nearly irresistible urge to move the legs, usually associated with limb discomfort. Symptoms typically occur at rest, in the evening, and are transiently relieved by...

Did You Know? Early Parkinson’s Disease Treatment Recommendations

Did You Know? Early Parkinson’s Disease Treatment Recommendations

Printer Friendly PDF Parkinson’s Disease - Awareness Month Spotlight Parkinson’s disease is a chronic, progressive neurodegenerative disease that affects movement. Cardinal motor symptoms include resting tremor, commonly described as “pill-rolling,” rigidity,...

Product Focus: Evusheld (tixagevimab-cilgavimab)

Product Focus: Evusheld (tixagevimab-cilgavimab)

Printer Friendly PDF Evusheld (tixagevimab-cilgavimab) EMERGENCY USE AUTHORIZATION Tixagevimab-cilgavimab is authorized under the EUA to be used for the pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and pediatric individuals (12 years of...

Did You Know? Loop Diuretics

Did You Know? Loop Diuretics

Printer Friendly PDF Main Indications: Fluid retention in heart failure and kidney diseaseHypertension Special notes: The loop diuretics are more potent diuretics than thiazides, but less effective antihypertensives in most patients.1Loop diuretics are recommended...

Product Focus: PAXLOVID

Product Focus: PAXLOVID

Printer Friendly PDF PAXLOVID - Oral Antiviral Treatment for COVID-19 The FDA has recently granted emergency use authorization (EUA) for PAXLOVID. Paxlovid is nirmatrelvir tablets co-packaged with ritonavir tablets, both antiviral agents. Both agents must be...

Product Focus: MOLNUPIRAVIR

Product Focus: MOLNUPIRAVIR

Printer Friendly PDF MOLNUPIRAVIR - Oral Antiviral Treatment for COVID-19 The FDA has recently granted emergency use authorization (EUA) for molnupiravir (Lagevrio). Molnupiravir is an antiviral agent. In a recent clinical trial, molnupiravir reduced the risk of...

Did You Know? Deprescribing

Did You Know? Deprescribing

Printer Friendly PDF What is deprescribing? Let’s start with a couple of definitions! “Deprescribing is the planned and supervised process of dose reduction or stopping of medication that might be causing harm, or no longer be of benefit. Deprescribing is part of good...

Did You Know? Transdermal

Did You Know? Transdermal

Printer Friendly PDF Transdermal Patch Application Information Generic Name:BuprenorphineApplication• Apply to upper outer arm, upper chest or back, or side of chest• Remove hair at application site if needed• Press in place for 15 seconds• Replace weekly• Avoid same...

Did You Know? Probiotics

Did You Know? Probiotics

Probiotics: Probiotics are dietary supplements that contain living organisms normally found in our bodies that don’t usually cause illness. They are often promoted to strengthen the immune system or recolonize the gut or vagina.The most common organisms used in...

Did You Know? Influenza (Flu) vs SARS-CoV-2 (COVID-19)

Did You Know? Influenza (Flu) vs SARS-CoV-2 (COVID-19)

The Flu and COVID-19 have several overlapping features: Both are contagious respiratory illnesses that are caused by viruses. They can both spread from person-to-person, who are in close contact (within about 6 feet of one another). They are both spread mainly by...